Semaglutide and Tirzepatide, medications commonly used to treat type 2 diabetes and for weight management, have gained considerable attention recently. Here are some frequently asked questions (FAQs):
Semaglutide is the active ingredient found in name-brand medications like Ozempic®. Semaglutide is a glucagon-like-peptide-1 receptor agonist prescribed as an additional weight loss support to a healthy diet and exercise regimen for weight loss and weight management.
In June of 2021, the FDA approved semaglutide for weight loss.
Semaglutide acts like GLP-1 (a gut hormone) to increase insulin production, decrease glucagon synthesis, and suppress hunger. It sends a signal to your brain that you are full, so you can lose weight without feeling like you are starving yourself.
While Tirzepatide and semaglutide both decrease the feelings of hunger, Tirzepatide is also a GIP receptor. GIP is a hormone produced by the small intestine that increases insulin release after eating food.
If you are struggling to lower your blood sugar and reach your A1C goal, semaglutide or tirzepatidecould be your solution!
Have you tried so many other kinds of weight loss products, with no results?
Semaglutide and Tirzepatide are proven to lower A1C, lowers the risk of major cardiovascular events like stroke or heart attacks, and can help you lose weight.
Semaglutide is marketed under other brand names like Ozempic and Wegovy.
Tirzepatide is marketed under brand names like Zepbound.
Every person’s body responds differently to medications. There have been various studies conducted, and on average, over a year and a half period, participants in the study lost an average of 15% of their body weight, and 1/3 of participants lost over 20% of their body weight.
If you want to lose weight, have a BMI of 27 or higher, hypertension, Type 2 Diabetes, or hyperlipidemia, you may be a great candidate.
Do you have further questions? Consult with our physician!
If you:
It can be administered weekly, at any time of day, but on the same day every week.
It should be injected subcutaneously into your upper arm, abdomen, or your thigh.
Although there are rarely any side effects reported, with any medication, there might be some. Everyone’s experience is different. While rare, the most common side effects include nausea, diarrhea or constipation, a bloated feeling or an upset stomach, heartburn, dizziness, fatigue, headaches, or vomiting.
This depends on the amount of weight you desire to lose, and should be discussed with our physician on an ongoing basis in your follow ups.
Long-term studies are ongoing, but current data suggest that semaglutide and tirzepatide are generally safe when used as directed. Regular follow-ups with your healthcare provider are important to monitor any potential side effects or complications.
While we recommend sticking to a healthy diet for a lifestyle of wellness, not just temporarily for weight loss, there are no specific restrictions on what you can eat.
Yes. There are no exercise restrictions.
If you miss a dose, take it as soon as you remember, but skip it if the next dose is due in less than 48 hours. Then, continue with your regular schedule.
Semaglutide or tirzepatide alone is unlikely to cause hypoglycemia. However, when combined with other diabetes medications like insulin or sulfonylureas, the risk increases. Monitoring blood sugar levels is important.
Clinical trials have shown that semaglutide and tirzepatide can lead to significant weight loss. In some studies, participants lost up to 15-20% of their body weight over 68 weeks when combined with lifestyle modifications.
Inform your doctor about:
For weight loss, effects may become noticeable after several weeks to months, depending on the individual.
It’s not recommended to stop taking semaglutide or tirzepatide without consulting your healthcare provider. Abruptly stopping can lead to a return of high blood sugar levels in diabetics or weight regain in those using it for weight management.
Semaglutide and tirzepatide may interact with other medications, particularly those that affect blood sugar levels. It’s important to discuss all medications you’re taking with your healthcare provider.
Always consult with a healthcare professional before making any decisions related to the use of Semaglutide.
Semaglutide works solely as a GLP-1 receptor agonist in the brain, causing a lesser feeling of hunger and reduced cravings for food. Tirzepatide combines the actions of GLP-1 and GIP receptor agonists, providing a greater reduction in appetite than semaglutide by itself.